RA-induced differentiation in NB has also been linked to decreased chemosensitivity to antineoplastic agents, such as topotecan, doxorubicin and cisplatin, which is mediated through BCL-2 and BCL-XL upregulation [55]. The gene discussed is BCL2; the disease is neuroblastoma.